Porcine endogenous retroviral mRNAs in pancreas and a panel of tissues from specific pathogen-free pigs

Diabetes and Metabolism

Volumn 25, Issue 6, 1999, Pages 518-525

  Clemenceau B ^a   Lalain, S ^a   Martignat, L ^a   Sai P ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Pancreas; Pig endogenous retrovirus; Xenograft

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; NONHUMAN; PANCREAS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; VIRUS TRANSMISSION; XENOTRANSPLANTATION;

ANIMALS; BETARETROVIRUS; ENDOGENOUS RETROVIRUSES; GENES, ENV; GENES, GAG; GENES, POL; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, RIBOSOMAL, 18S; RNA, VIRAL; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE;

EID: 0343502986     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Groth CG. Transplantation of porcine fetal pancreas to diabetic patients. Lancet, 1994, 344, 1402-1404.
2. Bach FH, Fishman JA, Daniels N et al. Uncertainty in xenotransplantation: individual benefit versus collective risk. Nature Med, 1998, 4, 141-144.
3. Gouin E, Rivereau AS, Darquy S et al. Minimisation of microbial contamination for potential islet xenografts using specific pathogenfree pigs and a protected environment during tissue preparation. Diabetes Metab, 1997, 23, 537-540.
4. Gouin E, Rivereau AS, Duvivier V et al. Perifusion analysis of insulin secretion from specific pathogen-free large-white pig islets shows satisfactory functional characteristics for xenografts in humans. Diabetes Metab, 1997, 24, 208-214.
5. Todaro GJ, Benveniste RE, Lieber MM, Sherr CJ. Characterization of a type-C virus released from the porcine cell line PK(15). Virology, 1974, 58, 65-74.
6. Benveniste RE, Todaro GJ. Evolution of type-C viral genes: preservation of ancestral murine type-C viral sequences in pig cellular DNA. Proc Nat Acad Sci USA, 1975, 72, 4090-4094.
7. Tristem M, Kabat P, Lieberman L, Linde S, Karpas A, Hill F. Characterisation of a novel murine leukemic virus-related sub-group in mammals. J Virol, 1996, 70, 8241-8246.
8. Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss RA. Two sets of human-tropic pig retrovirus. Nature, 1997, 389, 681-682.
9. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nature Med, 1997, 3, 282-286.
10. Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee P, Fishman JA. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol, 1998, 72, 4503-4507.
11. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol. 1998, 72, 3082-3087.
12. Rogel-Gaillard C, Bourgeaux N, Billault A, Vaiman M, Chardon P. Construction of a swine BAC library: application to the characterization and mapping of porcine type C endoviral elements. Cytogenet Cell Genet, 1999, in press.
13. Martignat L, Saï P, Jestin A. Detection of porcine endogenous retrovirus: possible involvement in pig islet xenotransplantation. Diabetes Metab, 1998, 24, 434-441.
14. Armstrong JA, Porterfield JS, De Madrid AT. C-type virus particles in pig kidney cell lines. J Gen Virol, 1971, 10, 195-198.
15. Woods WA, Papas TS, Hirumi H, Chirigos MA. Antigenic and biochemical characterization of the C-type particle of the stable porcine kidney cell line PK-15. J Virol, 1973, 12, 1184-1186.
16. Moennig V, Frank H, Hunsmann G, Ohms P, Schwarz H, Schäfer W. C-type particles produced by a permanent cell line from a leukemic pig. Virology, 1974, 57, 179-188.
17. Bouillant AMP, Greig AS, Lieber MM, Torado GJ. Type C virus production by a continuous line of pig oviduct cells (PFT). J Gen Virol, 1975, 27, 173-180.
18. Lieber MM, Sherr CJ, Benveniste RE, Todaro GJ. Biologic and immunologic properties of porcine type C virus. Virology, 1975, 66, 616-619.
19. Frazier ME, Ushijima RN, Andrews TK, Hooper MJ. Comparative studies on cell lines established from normal and radiation-exposed miniature swine. In vitro, 1979, 15, 1001-1012.
20. Suzuka I, Sekiguchi K, Kodama M. Some characteristics of a porcine retrovirus from a cell line derived from swine malignant lymphomas. FEBS Lett, 1985, 183, 124-128.
21. Kadota K, Inoue T, Kodama M, Nakajima H, Ogihara K. Ultrastructural observation on cultured cells from swine immunoblastic sarcoma. Japanese Journal of Vetenary Science, 1988, 50, 1127-1130.
22. Kaeffer B, Bottreau E, Marcon D, Olivier M, Lantier I, Salmon H. Histocompatible miniature pig (d/d haplotype): generation of hybridomas secreting A or M monoclonal antibody. Hybridoma, 1991, 10, 731-744.
23. Martin U, Kiessig V, Blusch JH et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet, 1998, 352, 692-694.
24. Takeuchi Y, Patience C, Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol. 1998, 72, 9986-9991.
25. Martin U, Steinhoff G, Kiessig V et al. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int, 1998, 11, 247-251.
26. Heneine W, Tibell A, Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet, 1998, 352, 695-699.
27. Patience C, Patton GS. Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet, 1998, 352, 699-701.
28. Paradis K, Langford G, Long Z et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science. 1999, 285, 1236-1241.
29. Cariolet R. Bilan des 10 années d'utilisation de porcs exempts d'organismes pathogènes spécifiques (E.O.P.S.) à la station de pathologie porcine de Ploufragan. Journées de Recherche porcine en France, 1986, 18, 321-330.
30. Weiser B, Nachman S, Tropper P et al. Quantification of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Nail Acad Sci, 1994, 91, 8037-8041.
31. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther, 1990, 1, 111-123.
32. Purcell DP, Broscius C, Vanin EF, Buckler CE, Nienhuis AW, Martin MA. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol, 1996, 70, 887-897.